Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Endocrinol ; 225(2): R49-66, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25957191

RESUMO

Recently, kisspeptin (KP) and gonadotropin inhibitory hormone (GnIH), two counteracting neuropeptides, have been acknowledged as significant regulators of reproductive function. KP stimulates reproduction while GnIH inhibits it. These two neuropeptides seem to be pivotal for the modulation of reproductive activity in response to internal and external cues. It is well-documented that the current metabolic status of the body is closely linked to its reproductive output. However, how reproductive function is regulated by the body's energy status is less clear. Recent studies have suggested an active participation of hypothalamic KP and GnIH in the modulation of reproductive function according to available metabolic cues. Expression of KISS1, the KP encoding gene, is decreased while expression of RFRP (NPVF), the gene encoding GnIH, is increased in metabolic deficiency conditions. The lower levels of KP, as suggested by a decrease in KISS1 gene mRNA expression, during metabolic deficiency can be corrected by administration of exogenous KP, which leads to an increase in reproductive hormone levels. Likewise, administration of RF9, a GnIH receptor antagonist, can reverse the inhibitory effect of fasting on testosterone in monkeys. Together, it is likely that the integrated function of both these hypothalamic neuropeptides works as a reproductive output regulator in response to a change in metabolic status. In this review, we have summarized literature from nonprimate and primate studies that demonstrate the involvement of KP and GnIH in the metabolic regulation of reproduction.


Assuntos
Hormônios Hipotalâmicos/metabolismo , Kisspeptinas/metabolismo , Reprodução , Animais , Humanos , Hormônios Hipotalâmicos/genética , Hipotálamo/metabolismo , Kisspeptinas/genética
2.
Acta Neurochir Suppl ; 79: 109-11, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11974973

RESUMO

Most patients with neurofibromatosis type 2 (NF2) lose hearing either spontaneously or after removal of their neurofibromas. The patient may benefit from conventional hearing aids if, due to modern microsurgery and intraoperative monitoring the integrity of the cochlea and the 8th nerve is preserved. With lost auditory function but preserved electrical stimulibility of the 8th nerve a cochlear implant may be appropriate. But if the patients have no remaining 8th nerve to stimulate, there is no benefit from cochlear implants. Until some years ago, vibrotactile aids, lip-reading, and sign language have been the only communication modes available to these patients. With auditory brain stem implants it is now possible to bypass both the cochlea and the 8th nerve and to stimulate the cochlear nucleus directly. Stimulation of the devices produces useful auditory sensations in almost all patients. Testing of perceptual performance indicated significant benefit from the device for communication purposes, including sound-only sentence recognition scores and the ability to converse on the telephone. Also lip-reading is significantly improved with brain stem implants. The successful work of an auditory brainstem program center depends very much on the close interdisciplinary collaboration between the Departments of Neurosurgery and ENT-surgery. In the future new developments like speech processing strategies and new designed electrodes accessing the complex tonotopic organization of the cochlear nucleus may further improve rehabilitation in these patients who would have been deaf some years ago.


Assuntos
Comunicação , Audição , Neurofibromatose 2/reabilitação , Vias Auditivas/cirurgia , Tronco Encefálico/cirurgia , Terapia por Estimulação Elétrica/instrumentação , Terapia por Estimulação Elétrica/métodos , Humanos , Neurofibromatose 2/fisiopatologia , Neurofibromatose 2/psicologia , Próteses e Implantes
3.
Acta Neurochir Suppl ; 65: 44-9, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8738494

RESUMO

Thermoregulatory capabilities under physiologic cold and heat exposure of 37 patients with suprasellar pituitary adenomas (As) and 10 patients with intrasellar adenomas (Ai) were analyzed and compared to each other and to 13 controls (Ctr.) In Ai no shift of the thermoregulatory threshold temperatures was observed. In As the regulation was shifted to a 0.5 degrees C higher mean body temperature in 82% of the patients, indicating a "set-point" elevation. The accuracy of the regulation against thermal loads was maintained, the velocity was reduced. Postoperative examination of As revealed a normalisation of the "set-point". Modifications of the hypothalamic amine systems by the compressive effect of the suprasellar adenomas are discussed to be the most probable cause for the observed thermoregulatory alterations.


Assuntos
Adenoma/fisiopatologia , Regulação da Temperatura Corporal/fisiologia , Síndromes Endócrinas Paraneoplásicas/fisiopatologia , Neoplasias Hipofisárias/fisiopatologia , Adenoma/cirurgia , Adulto , Feminino , Seguimentos , Humanos , Hipotálamo/fisiopatologia , Masculino , Pessoa de Meia-Idade , Norepinefrina/fisiologia , Síndromes Endócrinas Paraneoplásicas/cirurgia , Hormônios Adeno-Hipofisários/metabolismo , Neoplasias Hipofisárias/cirurgia , Complicações Pós-Operatórias/fisiopatologia , Serotonina/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA